Kips Bay Medical (NSDQ:KIPS) launched the 1st feasibility trials aimed at gaining FDA investigational device clearance for its eSVS vascular mesh.
The eSVS is designed to help keep vein grafts open in patients undergoing coronary artery bypass surgery, according to the company’s brochure.